1. Home
  2. SONM vs CLRB Comparison

SONM vs CLRB Comparison

Compare SONM & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • CLRB
  • Stock Information
  • Founded
  • SONM 1999
  • CLRB 2002
  • Country
  • SONM United States
  • CLRB United States
  • Employees
  • SONM N/A
  • CLRB N/A
  • Industry
  • SONM Telecommunications Equipment
  • CLRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • CLRB Health Care
  • Exchange
  • SONM Nasdaq
  • CLRB Nasdaq
  • Market Cap
  • SONM 11.9M
  • CLRB 12.8M
  • IPO Year
  • SONM 2019
  • CLRB N/A
  • Fundamental
  • Price
  • SONM $11.33
  • CLRB $3.23
  • Analyst Decision
  • SONM
  • CLRB Hold
  • Analyst Count
  • SONM 0
  • CLRB 2
  • Target Price
  • SONM N/A
  • CLRB N/A
  • AVG Volume (30 Days)
  • SONM 57.6K
  • CLRB 349.9K
  • Earning Date
  • SONM 10-31-2025
  • CLRB 10-31-2025
  • Dividend Yield
  • SONM N/A
  • CLRB N/A
  • EPS Growth
  • SONM N/A
  • CLRB N/A
  • EPS
  • SONM N/A
  • CLRB N/A
  • Revenue
  • SONM $59,109,000.00
  • CLRB N/A
  • Revenue This Year
  • SONM $127.68
  • CLRB N/A
  • Revenue Next Year
  • SONM N/A
  • CLRB N/A
  • P/E Ratio
  • SONM N/A
  • CLRB N/A
  • Revenue Growth
  • SONM 4.17
  • CLRB N/A
  • 52 Week Low
  • SONM $9.38
  • CLRB $3.22
  • 52 Week High
  • SONM $114.84
  • CLRB $66.00
  • Technical
  • Relative Strength Index (RSI)
  • SONM 92.19
  • CLRB 30.08
  • Support Level
  • SONM $10.40
  • CLRB $3.70
  • Resistance Level
  • SONM $11.80
  • CLRB $3.43
  • Average True Range (ATR)
  • SONM 0.46
  • CLRB 0.30
  • MACD
  • SONM 0.99
  • CLRB -0.08
  • Stochastic Oscillator
  • SONM 91.67
  • CLRB 3.11

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: